Dr. David Gandara of the UC Davis Comprehensive Cancer Center talks about the drug pembrolizumab and its positive clinical trial results for patients with advanced lung cancer.

-----

UC Davis Comprehensive Cancer Center is committed to excellence in cancer care. Designated as a comprehensive cancer center by the National Cancer Institute, our approach to cancer care starts with teams of doctors who work together to develop the most effective treatment or combination of treatments for each patient. We also provide a full range of supportive care services for patients, including counseling and nutrition consulting. Our physicians conduct clinical research and collaborate closely with laboratory scientists, ensuring that new drugs, advanced biotechnologies and other treatments developed in the lab can move quickly to the clinic to benefit patients. Ranked among the nation’s best hospitals, we are breaking barriers to beat cancer.

Learn more at https://health.ucdavis.edu/cancer/abo...
Our cancer specialties: https://health.ucdavis.edu/cancer/spe...
Types of cancer we treat: https://health.ucdavis.edu/cancer/can...
Pediatric cancer care: https://health.ucdavis.edu/cancer/ped...
Beat Cancer podcast:    • Beat Cancer Podcast  
See the latest news from UC Davis Health: https://health.ucdavis.edu/newsroom

-----

The information in this video was accurate as of the upload date, 6/17/16. For information purposes only. Consult your local medical authority for advice.